Huiping Jiang is currently the Senior Vice President and Head of Regulatory Affairs/Quality Assurance at Valerio Therapeutics. Prior to this, they served as President (Interim) and Board Member at Qx Therapeutics Inc. Additionally, they held the position of Senior Vice President at Epizyme, Inc. Huiping Jiang has a Post Doctorial degree in Genetic Engineering and Molecular Genetics in Signal Transduction from Caltech, as well as a Ph.D. in Cell Biology and Molecular Biology from Clarkson University.
July 1, 2023 - present
April, 2022